Package 82009-080-60

Brand: tadalafil

Generic: tadalafil
NDC Package

Package Facts

Identity

Package NDC 82009-080-60
Digits Only 8200908060
Product NDC 82009-080
Description

60 TABLET in 1 BOTTLE (82009-080-60)

Marketing

Marketing Status
Marketed Since 2023-07-19
Brand tadalafil
Generic tadalafil
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f6dd0676-5e89-4c63-8a1c-7b594d23f304", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0382009080604"], "unii": ["742SXX0ICT"], "rxcui": ["2123194"], "spl_set_id": ["84cb16c8-30ab-49f2-a6df-ec3c97bf6284"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (82009-080-60)", "package_ndc": "82009-080-60", "marketing_start_date": "20230719"}], "brand_name": "Tadalafil", "product_id": "82009-080_f6dd0676-5e89-4c63-8a1c-7b594d23f304", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "82009-080", "generic_name": "Tadalafil", "labeler_name": "Quallent Pharmaceuticals Health LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "ANDA210392", "marketing_category": "ANDA", "marketing_start_date": "20230719", "listing_expiration_date": "20261231"}